Table 3 Multivariable regression analysis of the EYWHOLE and EYHARDEST associated with mVSS in 69 pathological scars.

From: Correlation between elastic modulus and clinical severity of pathological scars: a cross-sectional study

Exposure

Non−adjusted

Adjust I

Adjust II

EMWHOLE group

EMWHOLE (20.6–130.2)

Reference

Reference

Reference

EMWHOLE (130.6–408.0)

2.501 (1.198, 3.804), P = 0.0004

0.997 (−0.525, 2.520), P = 0.206

0.740 (−0.945, 2.426), P = 0.395

EMWHOLE group trend

0.020 (0.012, 0.029), P < 0.00001

0.010 (−0.001, 0.021), P = 0.095

0.009 (−0.002, 0.020), P = 0.126

Exposure

Non-adjusted

Adjust I*

Adjust II*

EMHARDEST group

EMHARDEST (19.7–188.9)

Reference

Reference

Reference

EMHARDEST (188.9–554.5)

2.704 (1.424, 3.984), P = 0.00010

0.924 (−0.403, 2.252), P = 0.178

1.304 (−0.299, 2.907), P = 0.118

EYHARDEST group trend

0.016 (0.011, 0.022), P < 0.00001

0.008 (0.002, 0.014), P = 0.015

0.009 (0.002, 0.016), P = 0.017

  1. Adjust I model is adjusted for: age; duration; etiology; treatment; scar location; scar length; scar width; echogenicity; subclinical fistulous tracts; supracutaneous height; intradermal height; blood flow type; blood flow distribution pattern; scar type.
  2. Adjust II model is adjusted for: age; duration; etiology; treatment; scar location; scar length; scar width; echogenicity; infiltration level; subclinical fistulous tracts; supracutaneous height; intradermal height; blood flow type; blood flow distribution pattern; Alder; scar type.
  3. Adjust I* model is adjusted for: age; duration; etiology; scar location; scar length; scar width; echogenicity; subclinical fistulous tracts; supracutaneous height; blood flow type; scar type.
  4. Adjust II* model is adjusted for: age; duration; etiology; scar location; scar length; scar width; echogenicity; infiltration level; subclinical fistulous tracts; supracutaneous height; blood flow type; blood flow distribution pattern; Alder; scar type.